article thumbnail

Abstract 4140139: Cardio-ankle vascular index (CAVI) in prediction of chronic coronary artery disease: risk, coronary artery lesions, and cardiovascular disease events

Circulation

Out of these, 162 patients had chronic coronary artery disease (CAD), while the remaining 62 patients were free of CAD. The study took place between October 2019 and December 2022. In addition, CAVI has a statistically significant increase in severe stenosis (≥75%) and multivessel coronary artery disease.

article thumbnail

Trends in prognosis and use of SGLT2i and GLP-1 RA in patients with diabetes and coronary artery disease

Cardiovascular Diabetology

Objective To explore trends in prognosis and use of glucose-lowering drugs (GLD) in patients with diabetes and coronary artery disease (CAD). Information on GLD (dispended 6 months before or after coronary angiography) was collected from the Swedish Prescribed Drug Registry.

article thumbnail

Safe Deferral of Coronary Computed Tomography Angiography for Patients With a Low Pretest Probability of Coronary Artery Disease in 2019 European Society of Cardiology Guidelines

Journal of the American Heart Association

BackgroundCoronary computed tomography angiography is increasingly used as the first‐line test for suspected coronary artery disease. PTP was calculated according to the 2013 and 2019 ESC guidelines. Updated 2019 ESC guidelines classified 72% of the patients as having low PTP, whose imaging could have been deferred.

article thumbnail

Abstract 4143007: Pericoronary fat attenuation index as a Novel Tool to predict the morbidity of new-onset atrial fibrillation in patients with myocardial infarction with nonobstructive coronary artery disease

Circulation

Background:Myocardial infarction with nonobstructive coronary artery disease (MINOCA) is a special syndrome with clear evidence of myocardial ischemia, but no clear stenosis of coronary artery imaging sign. Circulation, Volume 150, Issue Suppl_1 , Page A4143007-A4143007, November 12, 2024. month follow-up.

article thumbnail

Burden of cardiovascular disease on coronavirus disease 2019 hospitalizations in the USA

Coronary Artery Disease Journal

Background Patients with cardiovascular disease (CVD) and risk factors have increased rates of adverse events and mortality after hospitalization for coronavirus disease 2019 (COVID-19). 2.21) were also significantly higher for COVID-19 hospitalizations with coronary artery disease.

article thumbnail

7 Things You Can Do To Reduce Your Risk Even If You Already Have Heart Disease.

Dr. Paddy Barrett

A common feedback I get is that people with existing coronary artery disease feel like it doesn’t apply to them. Arguably, applying the principles of prevention offers more bang for buck in the short term for people WITH coronary artery disease than those without coronary artery disease.

article thumbnail

Use of downstream stress imaging tests for risk stratification of patients presenting to the emergency department with chest pain and low HEART score

Open Heart

Methods We prospectively included 1384 patients with LRHSs between March 2019 and March 2021. The primary endpoints included cardiac death, non-fatal myocardial infarction and unplanned coronary revascularisation. All the patients underwent NISI (involving myocardial perfusion imaging/stress echocardiography).